Chronic Bronchitis and Emphysema Diagnosis
Chronic Bronchitis and Emphysema Diagnosis
The diagnosis of COPD rests on one number and a set of descriptions. The number is the ratio between two volumes of air breathed out after a bronchodilator has been given; the descriptions are the symptoms, the degree of breathlessness, the exacerbations in the past year and the inflammation pattern. This page sets out what each test contributes, what it cannot show, and why a normal result is a real answer rather than a disappointment.
Spirometry — the test that decides, and why symptoms cannot
Spirometry is a forced breathing manoeuvre. It measures how much air can be blown out in the first second and how much in total, and it reports those two volumes together with their ratio. In obstructive disease the total takes longer to come out, so the first-second volume falls more than the total and the ratio drops.
The manoeuvre is then repeated after a bronchodilator, and the ratio measured at that point is what decides the diagnosis. This detail matters: without the bronchodilator you cannot tell fixed obstruction from the reversible narrowing of asthma, and people have been treated for years on the strength of a single pre-bronchodilator tracing.
The threshold itself deserves a word, because it is not perfectly behaved. Guidelines traditionally use a fixed ratio below which obstruction is defined, and this is simple and reproducible but tends to over-diagnose in older people and under-diagnose in younger ones, since the ratio falls slowly with age in everyone. Some services use a statistically derived lower limit of normal instead. Either way the question being asked is the same, and the answer should be reported as the numbers rather than as the word "positive".
The most useful thing to understand about this test is that symptoms cannot substitute for it, and the error runs in both directions. Someone who has coughed and produced sputum for fifteen years, whose ratio turns out to be normal, does not have COPD — and needs an explanation for the cough rather than a lifelong inhaler. Someone whose ratio is well below the threshold, who still works and still describes themselves as coping, does have COPD, and the absence of complaint is not evidence against it.
Technique decides whether any of it means anything. Bronchodilators are withheld for the interval your team specifies, the effort is repeated several times because the test depends on it, and a good quality tracing is one that looks like a good effort. A technically poor blow can look exactly like mild obstruction, which is one reason a single number in isolation is a weak basis for a decision.
Pulmonary function testing, including the bronchodilator manoeuvre, is carried out by our respiratory and critical care medicine department, and the trace is read together with your history rather than on its own — which is the difference between a value and an answer.
Severity, and why it takes more than one number
Severity in COPD used to be read from the lung-function figure alone. It is now described from three things, because they disagree often enough that any one of them alone is misleading.
| Dimension | What it records | Why it is needed |
|---|---|---|
| Airflow limitation | How far the first-second volume falls below the predicted value for that person | It is the most reproducible measure, and it says least about how the disease feels on a given day |
| Symptom burden | Breathlessness graded by which activity brings it on, or a standard symptom questionnaire | Two people with the same numbers can differ greatly in what they can do, and treatment follows the person |
| Exacerbation history | How many episodes occurred in the past year, and whether any needed hospital assessment | It predicts the next year better than the lung-function figure does, and it changes the aim of treatment |
The lung-function part is graded in bands — broadly, preserved, moderate, severe and very severe reduction — as an international convention that makes one report comparable with another. The bands are useful shorthand and poor descriptions of individuals, which is the reason the other two dimensions sit alongside them.
It follows that a person with worse numbers may be doing considerably more than a person with better ones, and the difference is usually deconditioning, weight, mood, sleep and the presence of other conditions. This is not a reason to doubt the numbers; it is the reason a treatment plan that only looks at the numbers is incomplete.
Severity is also not a fixed property. It is reassessed whenever treatment changes, and the reassessment is written into the plan with a date, so that the interval is a decision rather than a habit. The step changes that follow from it are set out on the treatment page.
Imaging — what CT adds that spirometry cannot
A chest X-ray is a reasonable first image. In emphysema it may show an over-inflated chest with flattened diaphragms and an enlarged space behind the breastbone, and in advanced disease it may show bullae — large air spaces where the lung has been destroyed. It also serves its traditional purpose of excluding other things.
CT answers different questions. It shows which kind of emphysema is present and where it sits — centred on the small airways, spread through the lobules, or clustered under the pleura — and it can quantify how much of the lung is affected. It shows whether the airways are thickened, whether there is bronchiectasis or another interstitial process, and whether there is a mass. That detail matters when a surgical or bronchoscopic option is being considered, and when someone with a smoking history is due for lung cancer screening.
One specific test is worth knowing about because it is easy to miss. Alpha-1 antitrypsin deficiency is an inherited cause of emphysema, and testing is worth arranging when the disease appears at a young age, when emphysema is worst in the lower zones, when there is a family history or associated liver problems, or when someone with very little smoking exposure has developed the disease. It is a blood test, it changes advice for relatives, and it makes stopping smoking even more urgent than usual.
Where a lesion in the lung needs to be sampled rather than watched, our respiratory and critical care medicine department provides radial-probe ultrasound bronchoscopy, which locates peripheral lesions and assesses the vessels inside them, and CT- or ultrasound-guided lung biopsy, performed with real-time guidance. Where snoring or daytime sleepiness suggests that breathing at night is part of the problem, the same department provides sleep studies.
Oxygen, carbon dioxide, and the numbers behind them
Two measurements describe how well the lungs are moving gas, and they are not the same measurement. A finger probe or ear probe reads oxygen saturation, the percentage of haemoglobin that is carrying oxygen; it is quick, painless and used as a screen. Arterial blood gases measure the actual pressure of oxygen dissolved in the blood, together with the pressure of carbon dioxide and the acidity — and these are what decide treatment when the saturation is borderline or the clinical picture does not fit.
In COPD the oxygen pressure tends to fall slowly, and the body adapts to a level that would make a healthy person feel unwell. That adaptation is why a low oxygen measurement can be a genuine surprise to the person it belongs to, and it is also why the measurement cannot be replaced by asking how someone feels.
Carbon dioxide is the other half of the picture, and it is the reason oxygen has to be given carefully in this disease. In some people with advanced COPD the drive to breathe depends partly on a low oxygen level, and giving oxygen without control can raise the carbon dioxide and make things worse. In an exacerbation, oxygen is therefore given to a target range rather than as freely as possible, and the range is set for the individual. Outside an exacerbation, a raised carbon dioxide level identifies a group for whom a specific treatment is considered.
It is worth stating plainly that a low oxygen level and a sensation of breathlessness are two different things. Someone who is not hypoxaemic can be very breathless, and someone with a low oxygen level may not feel breathless at all. That distinction is developed further on the treatment page, because it decides who oxygen helps and who it does not.
Which measurement is needed, how often it is repeated, and what the result means for treatment are decisions made with your history in front of the clinician reading it rather than from the number alone.
What it could be instead
Several conditions produce the same cluster of symptoms, and a diagnosis of COPD should account for why each of them was considered and set aside. Some of them coexist with it rather than replacing it.
| Condition | What separates it |
|---|---|
| Asthma | Earlier onset, symptoms that vary from day to day and are worse at night, a large response to a bronchodilator on testing, and often an allergic background. It can also coexist with COPD |
| Bronchiectasis | A large daily volume of purulent sputum going back years, with repeated chest infections; imaging shows dilated, thickened airways |
| Heart failure | Breathlessness lying flat, waking at night breathless, ankle swelling and a raised jugular venous pressure; the lung function may be normal |
| Tuberculosis | Weeks rather than years of cough, fever, night sweats and weight loss; it must be actively excluded where it is common |
| Interstitial lung disease | Progressive breathlessness with a dry cough, fine crackles at the lung bases, and a restrictive rather than obstructive pattern |
| Lung cancer | A new or changed cough, blood in the sputum, weight loss or persistent chest pain; a change in a long-standing symptom is the clue |
Overlap is the rule rather than the exception. A person can have COPD and bronchiectasis, or COPD and heart failure, or a picture that sits between asthma and COPD; in each case the treatment is built from the parts rather than from a single label. What specifically belongs to the treatment of each of these is outside this guide, and the approach to the disease itself is on the treatment page.
Two practical consequences follow. First, a diagnosis that was made on symptoms and never revisited should be revisited when the picture changes. Second, a symptom that is new — rather than worse — deserves its own explanation rather than being folded into the existing diagnosis.